AMPMX - Overview: Amphetamine-Type Stimulants Confirmation, Chain of Custody, Meconium
Detecting in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by...
BUPR - Overview: Buprenorphine Screen with Reflex, Random, Urine
Screening and confirmation for drug abuse or use of buprenorphine
BIVAL - Overview: Bivalirudin, Ecarin, Plasma
Monitoring of bivalirudin therapy for patients with prolonged baseline activated partial thromboplastin time
DASM5 - Overview: Drugs of Abuse Screen, Meconium 5
Identifying amphetamines (and methamphetamines), opiates, phencyclidine, as well as metabolites of cocaine and marijuana in meconium specimens
Measuring the delta-9 carboxy-tetrahydrocannabinol to creatinine ratio to detect use of tetrahydrocannabinol
SLEG - Overview: Legionella pneumophila (Legionnaires Disease), Antibody, Serum
Evaluating possible legionellosis (Legionnaires disease, Pontiac fever, extrapulmonary legionella infection caused by Legionella pneumophila)
OAU - Overview: Organic Acids Screen, Random, Urine
Diagnosis of inborn errors of metabolism
MPPG - Overview: Mumps Virus Antibody, IgG, Serum
Determination of postimmunization immune response of individuals to the mumps vaccine Documentation of previous infection with mumps virus in an individual with no previous record of immunization to mumps virus
RBPG - Overview: Rubella Antibodies, IgG, Serum
Determining immune status to the rubella virus
CIMRP - Overview: Coccidioides immitis/posadasii, Molecular Detection, PCR, Varies
Rapid detection of Coccidioides DNA, preferred method An aid in diagnosing coccidioidomycosis
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Detection of (1→3)-𝝱-D-glucan as a Marker of Invasive Fungal Disease - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the detection of (1→3)-β-D-glucan (BDG) in serum as a biomarker for the presence of invasive fungal infections....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....